中财网 中财网股票行情
益佰制药(600594)财务分析指标    年份：
截止日期2025-03-312024-12-312024-09-302024-06-302024-03-31
营业总收入(万元)50148.08217403.16171384.03116819.1457264.61
营业收入(万元)50148.08217403.16171384.03116819.1457264.61
营业总成本(万元)51964.51250901.92189375.68128528.7063520.37
营业成本(万元)19975.0482943.9964790.8143867.7722576.33
净利润(万元)-938.57-31741.43-16912.43-10645.39-6841.53
归属于母公司的净利润(万元)-938.57-31721.54-16915.13-10649.34-6845.48
营业利润(万元)-1047.81-31225.35-16347.15-10643.22-6773.12
利润总额(万元)-999.95-33252.07-17376.64-11402.45-6976.57
少数股东损益(万元)-204.21-1745.86-509.05-448.05-295.70
基本每股收益(元)-0.01(元)-0.40(元)-0.21(元)-0.13(元)-0.09(元)
稀释每股收益(元)-0.01(元)-0.40(元)-0.21(元)-0.13(元)-0.09(元)
非经常性损益(万元)627.76595.891048.12504.63--
扣除非经常性损益后净利润(万元)-1566.33-32317.43-17963.25-11153.97-7079.30
总资产(万元)399490.28409970.12416715.75440585.81452269.83
总负债(万元)140022.03149359.09139038.19155080.48157581.56
归属于母公司股东权益合计(万元)248037.27248975.85264805.57272572.34281602.92
股东权益合计(万元)259468.25260611.03277677.56285505.33294688.27
实收资本(股本)(万元)79192.7479192.7479192.7479192.7479192.74
资本公积(万元)65383.6765383.6765383.6765383.6765383.67
未分配利润(万元)74459.7375398.3090204.7196470.49105501.08
经营活动产生的现金流量净额(万元)752.648687.3019980.3320309.679575.45
经营活动现金流入小计(万元)53110.12255694.49206742.23149276.3776976.72
经营活动现金流出小计(万元)52357.48247007.18186761.89128966.6967401.26
投资活动产生的现金流量净额(万元)-664.88-10383.68-5638.59-3681.76-1064.88
投资活动现金流入小计(万元)2.251248.691229.361151.861150.85
投资活动现金流出小计(万元)667.1311632.376867.954833.622215.73
筹资活动产生的现金流量净额(万元)-6480.90-15970.64-23120.93-12873.58-1397.45
筹资活动现金流入小计(万元)22300.0056000.0038000.0023878.4214800.00
筹资活动现金流出小计(万元)28780.9071970.6461120.9336752.0016197.45
期末现金及现金等价物余额(万元)45507.4651900.7360787.6373322.4176681.19
最后修改日期2025-04-292025-04-282024-10-292024-08-262024-05-18
↑返回页顶↑

转至益佰制药（600594）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。